Loading organizations...
§ Venture Capital · Nanjing, China
Nanjing Kaiyuan Growth Capital Investments operates as a private capital investment firm, specializing in growth equity. The firm strategically deploys capital into companies poised for significant expansion, building diversified portfolios. Its investment approach provides financial backing and guidance to accelerate portfolio companies' development and market presence.
Specific details regarding the inception of Nanjing Kaiyuan Growth Capital Investments, including its founding date and founders, are not publicly disclosed. As a private investment entity, its operational philosophy centers on identifying robust market opportunities and applying a disciplined strategy to drive long-term value creation through capital allocation.
The firm primarily serves high-potential companies seeking capital for their next growth phase, from startups to more established businesses. Nanjing Kaiyuan Growth Capital Investments envisions fostering economic growth by supporting promising ventures, aiming to generate substantial returns through focused investment and active portfolio oversight.
Nanjing Kaiyuan Growth Capital Investments has 1 tracked investment across 1 company. The latest tracked deal is $21.0M Series A in Personal Genome Diagnostics in October 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2015 | Personal Genome Diagnostics | $21.0M Series A | Justin Klein | Questa Capital, Vensana Capital, Adam Fine |